1. Hughes IA, Houk C, Ahmed SF, Lee PA, LWPES/ESPE Consensus Group (2006): Consensus statement on management of intersex disorders. Arch Dis Child, 91:554-563.
2. Brown J, Warne G (2005): Practical management of the intersex child. J Pediatr Endocrinol Metab, 18:3-23.
3. Dayner JE, Lee PA, Houk CP (2004): Medical treatment of intersex: Parental perspectives. J Urol, 172:1762-1765.
4. Josso N, Rey R, Gonzales J (2007). Sexual differentiation. In Pediatric Endocrinology/ENDOTEXT.ORG (M New, Ed).
5. Park YS, Jameson J (2005): Transcriptional regulation of gonadal development and differentiation. Endocrinol, 146:1035-1042.
6. Achermann JC, Ito M, Ito M, Hindmarsh PC, Jameson JL (1999): A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans. Nature Genet, 22:125-126.
7. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R (1993): WT-1 is required for early kidney development. Cell, 74:679-691.
8. Val P, Swain A (2005): Mechanisms of Disease: normal and abnormal gonadal development and sex determination in mammals. Nat Clin Pract Urol, 2:616-627.
9. Koopman P, Gubbay J, Vivian N, Goodfellow P, Lovell-Badge R (1991): Male development of chromosomally female mice transgenic for SRY. Nature, 351:117-121.
10. Sinclair AH, Berta P, Palmer MD et al. (1990): A gene from the human sex determining region encodes a protein with homology to a conserved DNA-binding motif. Nature, 346:240-244.
11. Nikolova G, Vilain E (2006): Mechanisms of disease: Transcription factors in sex determination – relevance to human disorders of sex development. Nat Clin Pract Endocrinol Metab, 2:231-238.
12. Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredstead L, Treier AC, Treier M (2004): The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development, 131:933-942.
13. Bernard P, Harley VR (2007): Wnt4 action in gonadal development and sex determination. Intl J Biochem Cell Biol, 39:31-43.
14. Josso N (1992): Hormonal regulation of sexual differentiation. Sem Perinatol, 16:274.
15. Lubahn DB, Brown TR, Simental JA, Higgs HN, Migeon CJ, Wilson EM, French FS (1989): Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity. Proc Natl Acad Sci, 86:9534-9538.
16. Siiteri PK, Wilson JD (1974): Testosterone formation and metabolism during male sexual differentiation in the human embryo. JCEM, 38:113-125.
17. Wilson JD, Griffin JE, Russell DW (1993). Steroid 5α-reductase 2 deficiency. Endocr Rev; 14:577-593.
18. Mendonca BB, Domenice S, Costa EMF, et al. (2005). Male pseudohermaphroditism. In Pediatric Endocrinology/ENDOTEXT.ORG (M New, Ed).
19. Swyer GIM: Male pseudohermaphroditism: A hitherto undescribed form (1955): British Medical Journal, 2:709-712.
20. Bianco S, Agrifoglio V, Mannino F, Cefalu E, Cittadini E (1992): Successful pregnancy in a pure gonadal dysgenesis with karyotype 46,XY patient (Swyer's syndrome) following oocyte donation and hormonal treatment. Acta Eur Fertil, 23:37-38.
21. McCarty BM, Migeon CJ, Meyer-Bahlburg HFL, Zacur H, Wisniewski AB (2006): Medical and psychosexual outcome in women affected by complete gonadal dysgenesis. J Pediatr Endocrinol Metab, 19:873-877.
22. Migeon CJ and Berkovitz GD (1992): Congenital defects of the external genitalia in the newborn and prepubertal child. In Pediatric and Adolescent Gynecology (Eds. SE Carpenter & JA Rock). Raven Press, New York, NY, pp.77-94.
23. Migeon CJ, Berkovitz GD, Brown TR (1994): Sexual differentiation and ambiguity. In Wilkins: The Diagnosis and Treatment of Endocrine Disorders in Childhood and Adolescence, 4th Ed. (Eds. MS Kappy, RM Blizzard & CJ Migeon). Charles C Thomas Publisher, Springfield, IL.
24. Berkovitz GD, Fechner PY, Zacur HW et al. (1991): Clinical and pathologic spectrum of 46,XY gonadal dysgenesis: Its relevance to the understanding of sex differentiation. Medicine, 70:375-383.
25. Migeon CJ, Wisniewski AB, Gearhart JP, Meyer-Bahlburg HFL, Rock JA, Brown TR, Casella SJ, Maret A, Ngai KM, Money J, Berkovitz GD (2002): Ambiguous genitalia with perineoscrotal hypospadias in 46,XY individuals: Long-term medical, surgical and psychosexual outcome. Pediatrics, 110:e31.
26. Lee PA, Rock JA, Brown TR et al. (1982): Leydig cell hypofunction resulting in male pseudohermaphroditism. Fertil Steril, 37:675-679.
27. Lee PA, Mazur T, Danish R et al. (1980): Micropenis I: Criteria, etiologies and classification. Johns Hopkins Med J, 146:156-163.
28. Bin-Abbas B, Conte FA, Grumbach MM, Kaplan S (1999): Congenital hypogonadotropic hypogonadism and micropenis: Effect of testosterone treatment on adult penile size – Why sex reversal is not indicated. J Pediatr, 134:579-583.
29. Wisniewski AB, Migeon CJ, Gearhart JP et al. (2001): Congenital micropenis: Long-term medical, surgical and psychosexual follow-up of individuals raised male or female. Hormone Research, 56:3-11.
30. Walsh PC, Madden JD, Harrod MJ et al. (1974): Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med, 291:944-949.
31. Imperato-McGinley J, Zhu YS (2002). Androgens and male physiology the syndrome of 5α-reductase-2 deficiency. Molecular and Cellular Endocrinology; 198:51-59.
32. Katz MD, Kligman I, Cai LQ et al. (1997): Paternity by intrauterine insemination with sperm from a man with 5α-reductase-2 deficiency. N Engl J Med, 336:994-997.
33. Zhou Z-X, Wong C-I, Sar M, et al. (1994). The androgen receptor: an overview. Recent Prog Horm Res, 49:249-274.
34. The androgen receptor gene mutation database world wide web server, http://androgendb.mcgill.ca/
35. Gottlieb B, Trifiro M, Lumbroso R, Pinsky L (1997): The androgen receptor gene mutation database. Nucleic Acids Res, 25:158-162.
36. Migeon CJ, Wisniewski AB, Brown TR (2002). Androgen insensitivity syndrome. In Hormone Resistance and Hypersensitivity States (Ed. GP Chrousos). Lippincott Williams & Wilkins, Philadelphia, PA.
37. Wisniewski AB, Migeon CJ, Meyer-Bahlburg HFL et al. (2000): Complete androgen insensitivity syndrome: Long-term medical, surgical and psychosexual outcome. JCEM, 85:2664-2669.
38. Maes M, Lee PA, Jeffs RD et al. (1980): Phenotypic variation in a family with partial androgen insensitivity syndrome. Am J Dis Child, 134:470-473.
39. Donohoue PA, Parker KL, Migeon CJ (2001): Congenital adrenal hyperplasia. In The Metabolic & Molecular Bases of Inherited Diseases, 8th ed. (Eds. Scriver, Beaudet, Sly et al.) McGraw-Hill, New York, NY.
40. New MI (2006). 21-hydroxylase deficiency: classical & nonclassical congenital adrenal hyperplasia. In Pediatric Endocrinology/ENDOTEXT.ORG (M New, Ed).
41. Harada N, Ogawa H, Shozu M et al. (1992): Biochemical and molecular genetic analysis of placental aromatase (P-450 arom) deficiency. J Biol Chem, 267:4781-4785.
42. Wilkins L, Jones HW, Holman GH et al. (1959): Masculinization of the female fetus associated with administration of oral and intramuscular progestins during gestation: Non-adrenal female pseudohermaphroditism. JCEM, 18:559.
43. Hirose M (1999). The role of Wilms’ tumor genes. J Med Invest, 46:130-140.
44. Fischbach BV, Trout KL, Lewis J, Luis CA, Sika M (2005). WAGR syndrome: a clinical review of 54 cases. Pediatrics, 116:984-988.
45. Little S, Hanks S, King-Underwood L, et al. (2005). A WT1 exon 1 mutation in a child diagnosed with Denys-Drash syndrome. Pediatr Nephrol, 20:81-85.
46. Giordano J, Prior HM, Bamforth JS, Walter MA (2001). Genetic study of SOX9 in a case of campomelic dysplasia. Am J Med Genet, 98:176-181.
47. Granat T, Freri E, Caccia C, Setola V, Taroni F, Battaglia G (2005). Schizencephaly: clinical spectrum, epilepsy and pathogenesis. J Child Neurol, 20:313-318.
48. Sofatzis JA, Alexacos L, Skouteli KN et al. (1983). Malformed female genitalia in newborns with the VATER association. Acta Paediatr Scand, 72:923-924.
49. Berg JS, French SL, McCullough LB, et al. (2006). Ethical and legal implications of genetic testing in androgen insensitivity syndrome. J Pediatr, 150:434-438.
50. Money J, Hampson JG, Hampson JL (1955). Hermaphroditism: recommendations concerning assignment of sex, change of sex, and psychologic management. Bull Johns Hopkins Hosp, 97:284-300.
51. Money J, Hampson JG, Hampson JL (1957). Imprinting and the establishment of gender role. Arch Neurol & Psychiatry, 77:333-336.
52. Bouvattier C, Mignot B, Lefevre H, Morel Y, Bougneres P (2006): Impaired sexual activity in males adults with partial androgen insensitivity syndrome. JCEM, 91:3310-3315.
53. Long DN, Wisniewski AB, Migeon CJ (2004): Gender role across development in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficicency. J Pediatr Endocrinol Metab, 17:1367-1373.
54. Wisniewski AB, Migeon CJ, Malouf MA, Gearhart JP (2004): Psychosexual outcome in women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency: an emphasis on long-term surgical results. J Urology, 171:2497-2501.
55. Dessens AB, Slijper FM, Drop SL (2005): Gender dysphoria and gender change in chromosomal females with congenital adrenal hyperplasia. Arch Sex Behav, 32:389-397.
56. Hines M, Ahmed SF, Hughes IA (2003): Psychological outcomes and gender-related development in complete androgen insensitivity syndrome. Arch Sex Behav, 32:93-101.
57. Husmann DA (2004): The androgen insensitive micropenis: Long-term follow-up into adulthood. J Pediatr Endocrinol Metab, 17:1037-1041.
58. Lee PA, Houk CP (2004): Outcome studies among men with micropenis. J Pediatr Endocrinol Metab, 17:1043-1053.
59. Cohen-Kettenis PT (2005): Gender change in 46,XY persons with 5-alpha-reductase-2 deficiency and 17-beta-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav, 34:399-410.
60. Mendonca BB, Inacio M, Costa EMF et al. (2003): Male pseudohermaphroditism due to 5 alpha-reductase 2 deficiency: outcome of Brazilian cohort. Endocrinologist, 13:202-204.
61. Mazur T, Sandberg DE, Perrin MA, Gallagher JA, MacGillivray MH (2004): Male pseudohermaphroditism: Long-term quality of life outcome in five 46,XY individuals reared female. J Pediatr Endocrinol Metab, 17: 809-823.
62. Jürgensen M, Hiort O, Holterhus PM, Thyen U (2007): Gender role behavior in children with XY karyotype and disorders of sex development. Horm Behav, 51:443-453.
63. Meyer-Bahlburg HFL (1999). What causes low rates of child-bearing in congenital adrenal hyperplasia? JCEM, 84:1844-1847.
64. Joint LWPES/ESPE CAH Working Group (2003): Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. JCEM, 87:4048-4053.